THE reforms recommended by
the TGA Transparency Review
panel (PD yesterday) will help
demystify the regulatory process
for the community, according to
Medicines Australia (MA).
Welcoming the final report by
the Therapeutic Goods
Administration Transparency
Review panel, MA chief
executive Dr Brendan Shaw
said: “the TGA has made
significant progress in reforming
its business processes and we
are already seeing greater
transparency in the prescription
medicines sector”.
“The quality of information
provided by the TGA to
companies bringing new
medicines to market is now
better,” he added.
Improvements already in
place include upgrades to the
TGA website, in particular to
the search functions of the
product register.
Shaw said that although all
the recommendations may take
some time to put into place,
the review represents a
“significant step forward”.The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jul 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jul 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.